Jazz Pharmaceuticals (JAZZ)

Jazz Pharmaceuticals (JAZZ) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• JAZZ last traded at $216.44, 0.21% on the day.
• Jazz Pharmaceuticals: market cap $14.02B, P/E 14.2, revenue $4.60B over the last four quarters, next earnings 2026-11-02.
• Over the past year JAZZ returned 58.80%; year to date 27.32%.

Updated 2026-11-02 18:02 UTC